Due to clotting risk, US restricts use of Johnson & Johnson’s Covid vaccine

Due to clotting risk, US restricts use of Johnson & Johnson’s Covid vaccine

US Food and Drug Administration (FDA) Limited use of the Covid-19 vaccine Johnson & Johnson, I realized that this could cause blood clots.

Restriction only applies to older than 18 years Where there is no other option for inoculation and where a person wants to get the Jansen vaccine despite identified safety issues.

The FDA and the Centers for Disease Control and Prevention are continuously monitoring and investigating all suspected cases of thrombosis with thrombocytopenia syndrome reported by the Vaccine Side Effect Reporting System (VAERS).

Data analysis updated by the FDA and the Centers for Disease Control and Prevention 60 confirmed cases have been identified, including nine deaths

The FDA has established a reported incidence of thrombosis or thrombocytopenia syndrome of 3.23 per million doses of vaccine administered and The estimated death rate from thrombosis with thrombocytopenia syndrome is 0.48 per million doses of vaccine administered.

“We recognize the Janssen Covid-19 vaccine It still has a role to play in responding to the ongoing pandemic in the United States And all over the world community. “Our actions reflect our reassessment of the risk of STT following the introduction of this vaccine and limit the use of the vaccine to certain individuals,” said Peter Marks, director of the FDA’s Center for Biological Assessment and Research.

Also factors that put a person at risk for thrombosis with thrombocytopenic syndrome after receiving the Janssen Covid-19 vaccine they still don’t know each otherPay attention to the FDA.

Likewise, the U.S. Drug Enforcement Administration also believes that people with thrombosis with thrombocytopenia syndrome can quickly get worse. Despite prompt diagnosis and treatment, the condition can have devastating long-term health consequences.Because it has a high death rate.

FDA The availability of alternative vaccines against Covid-19 was also considered. Authorized and approved to protect against respiratory diseases, Pfizer or Moderna.

Source: La Neta Neta

follow:
\